BAFF drives B-cell expansion by suppressing AMPK-dependent FOXO3a-ATG5/BECN1 signaling
Year: 2026
Type: article
Abstract: B-cell activating factor (BAFF) is a key regulator of B-cell homeostasis and is implicated in autoimmune and malignant B-cell disorders, yet its role in autophagy regulation during B-cell expansion remains unclear. Here, we examined whether human soluble BAFF (hsBAFF) promotes B-cell proliferation and viability through an AMPK-dependent FOXO3a–ATG5/Beclin 1 (BECN1) pathway. In Raji cells, Daudi cells, and primary murine B cells, hsBAFF dose-dependently increased phosphorylation of FOXO3a at Ser253 and BECN1 at Ser295, upregulated Bcl-2 and Survivin, and reduced ATG5 and LC3-II expression. These changes were accompanied by fewer MDC-labeled acidic vacuoles and GFP-LC3 puncta, together with increased B-cell proliferation and viability. ATG5 overexpression or expression of phosphorylation-deficient BECN1(S295A) attenuated hsBAFF-induced autophagy suppression and growth promotion, whereas ATG5 or BECN1 knockdown, BECN1(S295D), or FOXO3a knockout potentiated these effects. Mechanistically, hsBAFF inhibited AMPK activity; pharmacological or genetic AMPK activation restored FOXO3a-dependent autophagy and restrained B-cell proliferation/viability, whereas AMPK inhibition intensified hsBAFF responses. These findings identify AMPK-dependent FOXO3a–ATG5/BECN1 signaling as an autophagic checkpoint controlling BAFF-driven B-cell expansion and survival.
Source: Cell Biology and Toxicology
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,190
Awards: G1298373751, G4698196708, G6890300280
OpenAlex ID: W7235984708
